12th Oct 2005 07:01
Advanced Medical Solutions Grp PLC12 October 2005 Advanced Medical Solutions Group plc ("AMS" or "the Company") AMS announces further progress with its expansion into the Japanese woundcare market Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that its partner in Japan for itsadvanced woundcare and wound closure product range has identified a further fourproducts for market evaluation, regulatory approval and subsequent marketing inJapan. AMS's Japanese partner, Nitto Medical Corporation, a division of Japan's NittoDenko Group, is now six months in to the regulatory approval process of thefirst AMS product identified for marketing. The product is expected to belaunched in 2006. The AMS products so far identified by Nitto Medical Corporation are subject to arange of regulatory requirements, from exempt to full clinical trials. As aresult, it is anticipated that products will be launched during 2006 and 2007. Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS, said: "I am pleased with the progress we are making in entering this major market forour products and look forward to seeing initial sales coming through next year.Japan provides a major new growth opportunity for the business. -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group